Assessment | Screening | Baseline | Week 2 | Week 4 | Week 6 | Week 8 | Week 10 | Week 12 | Ad hoc |
---|---|---|---|---|---|---|---|---|---|
Medical Confirmation of Eligibility, SCID-5 | x | Â | Â | Â | Â | Â | Â | Â | Â |
Clinical Bloodwork | x | Â | Â | Â | Â | Â | Â | Â | Â |
Randomization | x | x | Â | Â | Â | Â | Â | Â | Â |
HRSD-17 | x | x | x | Â | x | Â | Â | x | Â |
CGI | Â | x | x | Â | x | Â | Â | x | Â |
GAD-7 | Â | x | x | Â | x | Â | Â | x | Â |
WHOQOL-BREF | Â | x | x | Â | x | Â | Â | x | Â |
Minocycline dispensed | Â | x | x | Â | x | Â | Â | Â | Â |
TAU/Concomitant medication | Â | x | x | Â | x | Â | Â | x | Â |
Adverse Event Checks | Â | x | x | Â | x | Â | Â | x | x |
Physical health measures | Â | x | Â | Â | Â | Â | Â | Â | Â |
Biomarkers (CRP, cytokines) | Â | x | Â | Â | Â | Â | Â | x | Â |
Telephone contact | Â | Â | Â | x | Â | x | x | x | x |